AI is becoming an integral part of point-of-care workflows, influencing how information is presented and contextualized for clinicians in real time. As these tools are increasingly embedded into healthcare systems, leaders face the challenge of guiding AI use in ways that align with organizational priorities and support decision-making in critical areas such as medication dosing, drug interactions, infection prevention, and risk assessment.
This executive roundtable invites healthcare leaders to engage in an active peer discussion on how AI governance is evolving from policy and oversight into a visible, operational layer within clinical workflows. The conversation will explore how organizations are incorporating expert-in-the-loop models and fostering AI literacy as essential building blocks for how users engage with these tools. Together, participants will examine how governance, transparency, and content design can shape the role of AI as a support tool, aligning its outputs with enterprise goals and clinician needs.
Drawing on real‑world clinician engagement data and executive perspectives, the discussion will also address how organizations are responding to the use of unsanctioned tools by surfacing authoritative sources at key moments and aligning AI outputs with a unified evidence foundation across the care ecosystem. Attendees will leave with actionable perspectives on how future‑ready healthcare organizations are operationalizing AI governance at the point of care—fostering trust, accountability, and collaboration while ensuring AI remains grounded in expert oversight and transparent, evidence‑aligned content.